Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Proteome Res ; 13(11): 4659-67, 2014 Nov 07.
Article in English | MEDLINE | ID: mdl-24846694

ABSTRACT

Fuchs' endothelial corneal dystrophy (FECD) is a major corneal disorder affecting the innermost part of the cornea, leading to visual impairment. As the morphological changes in FECD are mainly observed in the extracellular matrix of the Descemet's membrane/endothelial layer, we determined the protein profiles of diseased and control tissues using two relative quantitation MS methods. The first quantitation method, based on the areas of the extracted ion chromatograms, quantified the 51 and 48 most abundant proteins of the Descemet's membrane/endothelial layer in patient and control tissues, respectively, of which 10 were significantly regulated. The results indicated that the level of type VIII collagen was unaltered even though the protein previously has been shown to be implicated in familial early-onset forms of the disease. Using the second relative quantitation method, iTRAQ, we identified 22 differentially regulated proteins, many of which are extracellular proteins known to be involved in proper assembly of the basement membrane in other tissues. In total, 26 differentially regulated proteins were identified, of which 6 proteins were regulated in both methods. These results support that the morphological changes observed in FECD are caused in part by an aberrant assembly of the extracellular matrix within the Descemet's membrane/endothelial layer.


Subject(s)
Descemet Membrane/metabolism , Extracellular Matrix Proteins/metabolism , Fuchs' Endothelial Dystrophy/metabolism , Gene Expression Regulation/physiology , Proteomics/methods , Amino Acids/analysis , Chromatography, Liquid , Female , Humans , Male , Tandem Mass Spectrometry/methods
2.
J Proteomics ; 75(9): 2685-96, 2012 May 17.
Article in English | MEDLINE | ID: mdl-22483997

ABSTRACT

Trans fatty acid intake has been correlated to an unfavorable plasma lipoprotein profile and an increased cardiovascular disease risk. The present study aimed to identify a plasma protein biomarker panel related to human intake of elaidic acid. The human liver cell line HepG2-SF was used as a model system, and the cells were maintained for seven days in serum-free medium containing 100 µM elaidic acid (trans∆9-C18:1), oleic acid (cis∆9-C18:1) or stearic acid (C18:0). The secretomes were analyzed by stable isotope labeling of amino acids in cell culture (SILAC), difference in gel electrophoresis (DIGE) and gene expression microarray analysis. Twelve proteins were found to be differentially regulated based on SILAC data (>1.3 fold change, P-value<0.05), 13 proteins were found to be differentially regulated based on DIGE analysis (>1.3 fold change, P-value<0.05), and 17 mRNA transcripts encoding extracellular proteins were determined to be affected (>1.3 fold change, P-value<0.01) following the addition of elaidic acid compared to oleic acid or stearic acid. The results revealed that 37 proteins were regulated specifically in response to elaidic acid exposure, and nine of these proteins were confirmed to be regulated in this manner by using selected reaction monitoring mass spectrometry.


Subject(s)
Biomarkers/analysis , Dietary Fats/administration & dosage , Oleic Acid/administration & dosage , Proteins/isolation & purification , Trans Fatty Acids/administration & dosage , Carbon Radioisotopes , Culture Media , Electrophoresis, Polyacrylamide Gel , Hep G2 Cells , Humans , Liver/metabolism , Oleic Acid/metabolism , Oleic Acids , Oligonucleotide Array Sequence Analysis , RNA, Messenger/metabolism , Stearic Acids/metabolism , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...